当前位置： SCI文献检索 > Brachytherapy期刊下所有文献 > The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.

The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.

Abstract：

OBJECTIVES:Men with higher body mass index (BMI) tend to have more fatty tissue in prostate-rectum interface, which may reduce the rectal wall dose by the inverse square law. We hypothesized that men with higher BMI will have a lower dose to the rectal wall and less rectal toxicity after permanent prostate implant. METHODS:Prospectively collected data on rectal dosimetry/toxicity and BMI of 407 patients who underwent iodine-125 ((125)I) prostate implant were analyzed. Postimplant dosimetry used CT-MRI fusion on Day 30. Rectal wall was contoured on all slices where seeds were seen. The volume of rectal wall receiving the prescribed dose (RV(100) in cm(3)) and the dose to 1cc of rectal wall (RD(1cc)) were reported. Other factors evaluated for association with rectal dosimetry and toxicity included age, diabetes, hypertension, smoking, use of neoadjuvant hormones, T stage, baseline prostate volume, 1 month prostate edema, seed type and activity, and prostate dosimetry factors (the isodose enclosing 90% of the prostate volume [D(90)], the percentage of the prostate volume enclosed by the prescription [V(100)], and the percentage of the prostate volume enclosed by the 150% isodose [V(150)]). Rectal toxicity was reported as per Radiation Therapy Oncology Group criteria. RESULTS:BMIs ranged from 15.9 to 46.8 (mean+/-standard deviation [SD]: 27.8+/-4.2). The mean+/-SD values for RV(100) and RD(1cc) were 0.79+/-0.49cm(3) and 128.2+/-27.8Gy, respectively. There was a significant negative association of BMI with RV(100) (p=0.007) and RD(1cc) (p=0.01) on univariate analysis. The mean RV(100) and RD(1cc) for men with higher BMI (>27.8) were lower compared with their slimmer counterparts (0.70 vs. 0.86cm(3) and 123.4 vs. 132.4Gy, respectively). On multivariate analysis for RV(100) and RD(1cc), BMI remained significant (p-values 0.004 and 0.01, respectively) along with prostate volume and V(150), suggesting that anatomic factors are important in rectal dosimetry in prostate brachytherapy. Overall the incidence of Radiation Therapy Oncology Group acute rectal toxicity was 12% (Grade 2, 1.3%) and chronic 6% (Grade 2, 0.5%). No Grade 3 toxicity occurred. None of the factors evaluated were predictive for rectal toxicity. CONCLUSION:Men with a lower BMI received a higher rectal wall dose compared with those with higher BMI. This did not, however, translate into greater rectal toxicity.

journal_name

Brachytherapy

journal_title

Brachytherapy

authors

Patil N,Crook J,Saibishkumar EP,Aneja M,Borg J,Pond G,Ma C

doi

10.1016/j.brachy.2008.12.001

subject

Has Abstract

pub_date

2009-04-01 00:00:00

pages

218-222

issue

eissn

1538-4721

issn

1873-1449

pii

S1538-4721(08)00700-9

journal_volume

pub_type

杂志文章

在线工具

The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.